The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis
Open accessAbstract
BACKGROUND: Previous reports on molecular rapid diagnostic testing (mRDT) do not consistently demonstrate improved clinical outcomes in bloodstream infections (BSIs). This meta-analysis seeks to evaluate the impact of mRDT in improving clinical outcomes in BSIs. METHODS: We searched PubMed, CINAHL, Web of Science, and EMBASE through May 2016 for BSI studies comparing clinical outcomes between mRDT and conventional microbiology methods. RESULTS: Thirty-one studies were included with 5920 patients. The mortality risk was significantly lower with mRDT than with conventional microbiology methods (odds ratio [OR], 0.66; 95% confidence interval [CI], .54-.80), yielding a number needed to treat of 20. The mortality risk was slightly lower with mRDT in studies with antimicrobial stewardship programs (ASPs) (OR, 0.64; 95% CI, .51-.79), and non-ASP studies failed to demonstrate a significant decrease in mortality risk (0.72; .46-1.12). Significant decreases in mortality risk were observed with both gram-positive (OR, 0.73; 95% CI, .55-.97) and gram-negative organisms (0.51; .33-.78) but not yeast (0.90; .49-1.67). Time to effective therapy decreased by a weighted mean difference of -5.03 hours (95% CI, -8.60 to -1.45 hours), and length of stay decreased by -2.48 days (-3.90 to -1.06 days). CONCLUSIONS: For BSIs, mRDT was associated with significant decreases in mortality risk in the presence of a ASP, but not in its absence. mRDT also decreased the time to effective therapy and the length of stay. mRDT should be considered as part of the standard of care in patients with BSIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Ottawa Hospital Research Institute
(2015) · The SAGE Encyclopedia of Stem Cell Research · doi:10.4135/9781483347660.n335 · Cited by 855
Goto, M., & Al-Hasan, M. N. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12195 · Cited by 752
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
Caliendo, A. M., Gilbert, D. N., Ginocchio, C. C., Hanson, K. E., May, L., Quinn, T. C., Tenover, F. C., Alland, D., Blaschke, A. J., Bonomo, R. A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit578 · Cited by 628
Banerjee, R., Teng, C. B., Cunningham, S. A., Ihde, S. M., Steckelberg, J. M., Moriarty, J. P., Shah, N. D., Mandrekar, J. N., & Patel, R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ447 · Cited by 570 · cited 1×
“10 While a number of observational studies have supported the use of mRDT with ASPs for improving clinical outcomes, a recent randomized control trial has suggested these technologies have a limited impact [45].”
BackgroundHuang, A. M., Newton, D., Kunapuli, A., Gandhi, T. N., Washer, L. L., Isip, J., Collins, C. D., & Nagel, J. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit498 · Cited by 510
Perez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Land, G. A., Peterson, L. E., & Musser, J. M. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0651-oa · Cited by 388
Research works printed but not linked: 4
- 10.1016/j.jhin.2009.12.006 · doi:10.1016/j.jhin.2009.12.006
- Macvane SH , Nolte FS . Clinical impact of adding a rapid PCR-based blood culture identification panel (BCID) to an established antimicrobial stewardship intervention (ASI) program for patients with gram-negative bacteremia (GNB). [abstract 123]. In: Program and abstracts of the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego, CA). 2015.
- Maslonka M , Freifeld AG , Rupp ME et al . Impact of rapid bloodstream pathogen identification in hospitalized patients [abstract P171]. In: Program and abstracts of IDWeek (Philadelphia, PA). 2014. · doi:10.1093/ofid/ofu052.37
- 10.1128/JCM.00104-15 · doi:10.1128/jcm.00104-15
Cited by
Hassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
Bloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Doern, G. V., Carroll, K. C., Diekema, D. J., Garey, K. W., Rupp, M. E., Weinstein, M. P., & Sexton, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-19 · Cited by 313
Syndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
Surviving sepsis campaign: research priorities for sepsis and septic shock
Coopersmith, C. M., De Backer, D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martin-Loeches, I., Nunnally, M. E., Antonelli, M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5175-z · Cited by 281
Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30477-1 · Cited by 279
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Kim, J. I., Maguire, F., Tsang, K. K., Gouliouris, T., Peacock, S. J., McAllister, T. A., McArthur, A. G., & Beiko, R. G. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00179-21 · Cited by 256
Bloodstream infections – Standard and progress in pathogen diagnostics
Lamy, B., Sundqvist, M., & Idelevich, E. A. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.017 · Cited by 250
Tabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05866-w · Cited by 191
Diagnostic Stewardship: Opportunity for a Laboratory–Infectious Diseases Partnership
Patel, R., & Fang, F. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy077 · Cited by 127
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Tansarli, G. S., Andreatos, N., Pliakos, E. E., & Mylonakis, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02495-18 · Cited by 56
Self-citationThorndike, J., & Kollef, M. H. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000751 · Cited by 42
MacVane, S. H., & Dwivedi, H. P. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae282 · Cited by 36
Ohnuma, T., Chihara, S., Costin, B., Treggiari, M., Bartz, R. R., Raghunathan, K., & Krishnamoorthy, V. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005870 · Cited by 35
Babowicz, F., LaPlante, R., Mitchell, C., O’Donnell, J. N., Tobin, E., George, M., & Carreno, J. J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02364-20 · Cited by 28
Choi, J. J., Westblade, L. F., Gottesdiener, L. S., Liang, K., Li, H. A., Wehmeyer, G. T., Glesby, M. J., & Simon, M. S. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab467 · Cited by 21
Abbott, A. N., & Fang, F. C. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.08.004 · Cited by 13
Morquin, D., Lejeune, J., Agostini, C., Godreuil, S., Reynes, J., Le Moing, V., & Lamy, B. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciad744 · Cited by 9
Optimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
Clinical Outcomes of Early Phenotype-Desirable Antimicrobial Therapy for Enterobacterales Bacteremia
Moon, R. C., MacVane, S. H., David, J., Morton, J. B., Rosenthal, N., & Claeys, K. C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.51633 · Cited by 8
Self-citationChirio, D., Demonchy, E., Le Marechal, M., Gaudart, A., Lotte, R., Carles, M., & Ruimy, R. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0667 · Cited by 8
Teoh, T., Powell, J., O’Keeffe, J., Donlon, E., Dillon, L., Lenihan, M., Mostyn, A., Power, L., Boers, P., Stapleton, P. J., et al. (2022) · PloS One · doi:10.1371/journal.pone.0265187 · Cited by 7
“meta-analyses of the benefits of rapid molecular diagnostic on mortality in blood stream infection [21].”
Background
Metadata
- Authors
- Timbrook, T. T., Morton, J. B., McConeghy, K. W., Caffrey, A. R., Mylonakis, E., & LaPlante, K. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-09-26
- Volume
- 64
- Issue
- 1
- Pages
- 15-23
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2525326149
- Cited by
- 569
- References
- 40
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.